Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
Merck
MRK
|
+$362M |
| 2 |
Prologis
PLD
|
+$358M |
| 3 |
NVIDIA
NVDA
|
+$305M |
| 4 |
Corteva
CTVA
|
+$235M |
| 5 |
Atlassian
TEAM
|
+$226M |
Top Sells
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.8B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$308M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$261M |
| 4 |
iShares Russell 1000 Growth ETF
IWF
|
+$259M |
| 5 |
Danaher
DHR
|
+$243M |
Sector Composition
| 1 | Technology | 22.57% |
| 2 | Healthcare | 14.16% |
| 3 | Financials | 12.95% |
| 4 | Consumer Discretionary | 9.77% |
| 5 | Industrials | 9.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IBTX
1726
DELISTED
Independent Bank Group, Inc.
IBTX
| $6.55M | ﹤0.01% |
109,015
-18,403
| -14% | -$1.11M |
|
1727
RAPT Therapeutics
RAPT
$268M
| $6.55M | ﹤0.01% |
41,341
+4,580
| +12% | +$725K |
|
1728
Golar LNG
GLNG
$4.16B
| $6.52M | ﹤0.01% |
285,927
-148,523
| -34% | -$3.39M |
|
1729
Archrock
AROC
$4.29B
| $6.51M | ﹤0.01% |
725,360
-307,347
| -30% | -$2.76M |
|
1730
Kemper
KMPR
$3.35B
| $6.49M | ﹤0.01% |
131,853
-25,937
| -16% | -$1.28M |
|
1731
AMC Entertainment Holdings
AMC
$1.44B
| $6.45M | ﹤0.01% |
158,420
-40,742
| -20% | -$1.66M |
|
1732
Applovin
APP
$197B
| $6.45M | ﹤0.01% |
612,195
-8,577
| -1% | -$90.3K |
|
1733
Pacira BioSciences
PCRX
$1.22B
| $6.45M | ﹤0.01% |
166,980
-228,370
| -58% | -$8.82M |
|
1734
Nuveen ESG Large-Cap ETF
NULC
$51.3M
| $6.44M | ﹤0.01% |
200,000
-193,850
| -49% | -$6.25M |
|
1735
Snap
SNAP
$12.4B
| $6.44M | ﹤0.01% |
719,726
+44,293
| +7% | +$396K |
|
1736
Unitil
UTL
$827M
| $6.44M | ﹤0.01% |
125,370
-17,067
| -12% | -$877K |
|
1737
News Corp Class B
NWS
$18.2B
| $6.42M | ﹤0.01% |
347,988
-58,917
| -14% | -$1.09M |
|
1738
QCR Holdings
QCRH
$1.3B
| $6.41M | ﹤0.01% |
129,054
-12,829
| -9% | -$637K |
|
1739
Conduent
CNDT
$445M
| $6.4M | ﹤0.01% |
1,581,053
-377,948
| -19% | -$1.53M |
|
1740
Quaker Houghton
KWR
$2.46B
| $6.4M | ﹤0.01% |
38,322
-3,464
| -8% | -$578K |
|
|
IMGN
1741
DELISTED
Immunogen Inc
IMGN
| $6.39M | ﹤0.01% |
1,288,180
+634,141
| +97% | +$3.15M |
|
|
CPE
1742
DELISTED
Callon Petroleum Company
CPE
| $6.38M | ﹤0.01% |
172,132
-19,332
| -10% | -$717K |
|
1743
Genesco
GCO
$358M
| $6.38M | ﹤0.01% |
138,594
-101,944
| -42% | -$4.69M |
|
1744
Green Dot
GDOT
$751M
| $6.38M | ﹤0.01% |
403,272
-72,492
| -15% | -$1.15M |
|
1745
A10 Networks
ATEN
$1.26B
| $6.38M | ﹤0.01% |
383,356
+171,815
| +81% | +$2.86M |
|
1746
Goosehead Insurance
GSHD
$2.05B
| $6.36M | ﹤0.01% |
185,152
+131,451
| +245% | +$4.51M |
|
1747
Esperion Therapeutics
ESPR
$573M
| $6.35M | ﹤0.01% |
1,019,196
+717,837
| +238% | +$4.47M |
|
1748
Kaiser Aluminum
KALU
$1.24B
| $6.33M | ﹤0.01% |
83,329
-20,134
| -19% | -$1.53M |
|
1749
Ventyx Biosciences
VTYX
$164M
| $6.33M | ﹤0.01% |
192,933
+123,882
| +179% | +$4.06M |
|
|
AMED
1750
DELISTED
Amedisys
AMED
| $6.28M | ﹤0.01% |
75,183
-2,357
| -3% | -$197K |
|